A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2)

by Liu, J.-Y, Wang, H.-X, Xu, P.-P, Yu, W.-D, Zeng, M.-S
Published 2021

Characterization of the NiRAN domain from RNA-dependent RNA polymerase provides insights into a potential therapeutic target against SARS-CoV-2

by Ahmad, M., Bhattacharyya, S., Biswal, B.K, Chakraborty, S., Dwivedy, A., Jeyakanthan, J., Kar, D., Majumdar, T., Mani, S., Mariadasse, R., Sonar, S., Tailor, P., Tiwari, S.
Published 2021

Denovo designing, retro-combinatorial synthesis, and molecular dynamics analysis identify novel antiviral VTRM1.1 against RNA-dependent RNA polymerase of SARS CoV2 virus

by Tiwari, V.
Published 2021

Plasma LDH: A specific biomarker for lung affectation in COVID-19?

by Arenas, J., Blázquez, A., COVID-19 '12 Octubre' Hospital Clinical Biochemistry Study Group, Coya, O.N, Cueto-Felgueroso, C., de Miguel-Reyes, M., Delmiro, A., López-Jimenez, A., Lucia, A., Martín, M.A, Pozo, A.F.-D, Santos-Lozano, A., Serrano-Lorenzo, P.
Published 2021

Ritonavir may inhibit exoribonuclease activity of nsp14 from the SARS-CoV-2 virus and potentiate the activity of chain terminating drugs

by Nair, D.T, Narayanan, N.
Published 2021

Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort

by Bahram, S., Bastard, P., Bernard, A., Bibi-Triki, S., Carapito, C., Carapito, R., Casanova, J.-L, Chamaraux-Tran, T.-N, Chittenden, T.W, Collange, O., Danion, F., Drenou, B., Fafi-Kremer, S., Frappier, J., Gervais, A., Goichot, B., Guimaraes, R., Gujja, S., Gulcher, J.R, Hanauer, A., Hansmann, Y., Helms, J., Hermine, O., Hirschler, A., Javad Aman, M., Kailasan, S., Kuteifan, K., Larnicol, A., Laumond, G., Lederle, A., Li, R., Lidar, D., Macquin, C., Malagon-Lopez, J., Mariette, X., Mayeur, S., Mertes, P.-M, Meziani, F., Mohseninia, R., Molitor, A., Moog, C., Muller, L., Nilsson, P., Paul, N., Pichot, A., Pin, E., Pottecher, J., Radosavljevic, M., Rolli, V., Ruch, Y., Sanlaville, D., Schenck, M., Schmidt, S., Schneider, F., Sibilia, J., Simons, M., Spinnhirny, P., Stemmelen, T., Tahar, O., Tharaux, P.-L, Thomas, A., Viari, A., Wu, H., Zhang, Q.
Published 2022

Severe Acute Respiratory Syndrome Coronavirus 2 Antigens as Targets of Antibody Responses

by Cheng, C.-A, Gilboa, T., Lazarovits, R., Ogata, A.F, Uwamanzu-Nna, A., Walt, D.R
Published 2022

Comparison of virus neutralization activity and results of 10 different anti-SARS-CoV-2 serological tests in COVID-19 recovered plasma donors

by Barabás, E., Berki, T., Bodó, K., Fodor, E., Földes, F., Jakab, F., Kemenesi, G., Kristóf, K., Lacza, Z., Prohászka, Z., Szabó, T., Szabó, Z., Vásárhelyi, B.
Published 2021

Comparative genomic analysis reveals varying levels of mammalian adaptation to coronavirus infections

by King, S.B, Singh, M.
Published 2021

Mesenchymal Stem Cell-Based COVID-19 Therapy: Bioengineering Perspectives

by Karakaş, N., Karaoğlan, B.S, Öztürk, G., Shah, K., Üçüncüoğlu, S., Uludağ, D.
Published 2022

Genome-scale CRISPR screens identify host factors that promote human coronavirus infection

by Bluhm, A.P, Grodzki, M., Karst, S.M, Norris, M.H, Rafiee, R., Russo, M., Schaefer, M., Sobh, A., Tagmount, A., Vulpe, C.D
Published 2022

Large scale production and characterization of SARS-CoV-2 whole antigen for serological test development

by Brogi, A., Castria, M., Cerutti, H., Ricci, V., Soldatini, C., Tesi, G., Toppi, S., Tornesi, S., Vaccaro, M.N, Verdiani, S.
Published 2021

Assessment of antiphospholipid antibodies and calprotectin as biomarkers for discriminating mild from severe COVID-19

by Lee, A., Lee, J.-S, Lee, K.-R, Lee, M.-K, Nahm, C.H
Published 2021

Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective

by Baldwin, J., Honda-Okubo, Y., Li, L., Petrovsky, N., Piplani, S., Sakala, I.G
Published 2021

Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19

by Charland, N.C, Filbin, M.R, Goldberg, M.B, Gonye, A.L.K, Gushterova, I., Hacohen, N., Kays, K.R, Khanna, H.K, LaSalle, T.J, Lavin-Parsons, K.M, Leisman, D.E, Lilley, B.M, Lodenstein, C.L, Manakongtreecheep, K., Margolin, J.D, McKaig, B.N, Mehta, A., Parry, B.A, Rojas-Lopez, M., Russo, B.C, Sade-Feldman, M., Sharma, N., Tantivit, J., Thomas, M.F, Thompson, B.T, Villani, A.-C
Published 2022

Epigallocatechin-3-gallate, an active ingredient of Traditional Chinese Medicines, inhibits the 3CLpro activity of SARS-CoV-2

by Alsaadawe, M., Chen, X., Chen, Z., Disoma, C., Dong, Z., Du, A., Hu, L., Jiang, T., Li, S., Li, S., Li, S., Liu, P., Liu, S., Mo, L., Peng, J., Peng, Y., Razzaq, A., Shen, Y., Xia, Z., Yang, Q., Zhang, Q., Zhang, Y., Zheng, R., Zhou, Y.
Published 2021